Board of Directors

David Chiswell, Ph.D.

Chairman of the Board, Albireo; Former Chief Executive Officer, Kymab; Non-Executive Chairman, IGEM Therapeutics; Board Member of Bond 2 Development 2 GP

Read More

Anne Klibanski, M.D.

Laurie Carrol Guthart Professor of Medicine and Academic Dean for Partners, Harvard Medical School; President and CEO, Partners HealthCare; Chief Academic Officer, Partners HealthCare

Read More

Michael Gutch, Ph.D.

Chief Business Officer and Chief Financial Officer, Entasis Therapeutics

Read More

Roger A. Jeffs, Ph.D.

Former President and co-CEO, United Therapeutics (retired)

Read More

Stephanie S. Okey, M.S.

Former Senior Vice President, Head of North America, Rare Diseases, Genzyme, a Sanofi Company

Read More

Davey S. Scoon

Chair of the Board of Trustees, Allianz Global Investors

Read More

Ron Cooper

President and Chief Executive Officer

Read More